PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 39 filers reported holding PROTARA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,138 | -48.6% | 18,047 | -26.5% | 0.00% | – |
| Q2 2023 | $58,670 | +71448.8% | 24,548 | -6.7% | 0.00% | – |
| Q1 2023 | $82 | +3.8% | 26,321 | -11.2% | 0.00% | – |
| Q4 2022 | $79 | -99.9% | 29,626 | -41.0% | 0.00% | – |
| Q3 2022 | $149,000 | -16.3% | 50,207 | -17.4% | 0.00% | – |
| Q2 2022 | $178,000 | -51.9% | 60,784 | -16.0% | 0.00% | – |
| Q1 2022 | $370,000 | -48.4% | 72,350 | -31.9% | 0.00% | – |
| Q4 2021 | $717,000 | -1.2% | 106,245 | +1.3% | 0.00% | – |
| Q3 2021 | $726,000 | -42.4% | 104,918 | -18.9% | 0.00% | -100.0% |
| Q2 2021 | $1,260,000 | +33.1% | 129,380 | +115.2% | 0.00% | 0.0% |
| Q1 2021 | $947,000 | -29.2% | 60,134 | +8.8% | 0.00% | 0.0% |
| Q4 2020 | $1,338,000 | +109.7% | 55,259 | +45.7% | 0.00% | 0.0% |
| Q3 2020 | $638,000 | +135.4% | 37,928 | +310.9% | 0.00% | – |
| Q2 2020 | $271,000 | – | 9,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,558,472 | $43,059,000 | 8.42% |
| CVI Holdings, LLC | 168,836 | $2,842,000 | 1.16% |
| Soleus Capital Management, L.P. | 100,000 | $1,683,000 | 0.89% |
| Ikarian Capital, LLC | 722,443 | $12,158,000 | 0.88% |
| COWEN AND COMPANY, LLC | 124,171 | $2,090,000 | 0.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 782,670 | $13,172,000 | 0.32% |
| Cormorant Asset Management, LP | 450,000 | $7,574,000 | 0.29% |
| Rock Springs Capital Management LP | 643,622 | $10,832,000 | 0.28% |
| Perceptive Advisors | 608,544 | $10,242,000 | 0.15% |
| Maven Securities LTD | 100,000 | $1,688,000 | 0.14% |